Imiba ye-FDA 'Yokwaphulwa Okumandundu' Isilumkiso kuMenzi we-Ozempic Ngokubhubha Okungaxelwanga
I-FDA ikhuphe isilumkiso solwaphulo-mthetho olubi kuNovo Nordisk, umenzi weOzempic kunye Wegovy. I-arhente ityhola ukuba inkampani ayiphumelelanga ukuphanda ngokufanelekileyo kwaye inike ingxelo ngeziganeko ezimbi, kubandakanya ukusweleka kwabantu abaninzi. Olu phuhliso lunempembelelo ebalulekileyo kukhuseleko lwesigulane kunye nokuthotyelwa kwemithetho kwishishini lamachiza.
Iinkcukacha zeziphumo ze-FDA
Isilumkiso sivela kuhlolo lwe-2025 lwezixhobo zeNovo Nordisk. I-FDA ichonge amaxesha amaninzi kwiinkqubo ze-pharmacovigilance zenkampani. Olu tshintsho lubandakanya iziganeko ezimbi ezingaxelwanga.
Ngokutsho kwe-FDA, inkampani ayizange ilandele iiprotocol ezigunyazisiweyo. Oku kuquka ukusilela ukungenisa iingxelo kwangethuba ngeziphumo zesigulana. Uhlolo lubonise ukuba ukusweleka kwabantu abaninzi akuzange kubhalwe kakuhle okanye kuphandwe.
Ukwaphulwa okuKhethekileyo okuphawulwe yi-FDA
Ileta ye-FDA eya kwi-Novo Nordisk yachaza ukunyhashwa okungundoqo okuninzi. Ezi ziquka:
- Ukungaphumeleli ukuphuhlisa iinkqubo ezibhaliweyo zokunika ingxelo yokhuseleko
- Uphando olunganelanga malunga nokusweleka kwezigulana okunokunxulunyaniswa ne-Ozempic okanye i-Wegovy
- Ulibaziseko ekungeniseni iingxelo zesiganeko esisinyanzelo esisinyanzelo kwabasemagunyeni abalawulayo
Le miba iphakamisa inkxalabo malunga nokungafihli kunye nokuphendula. Izigulane kunye nababoneleli bezempilo baxhomekeke kwidatha echanekileyo yokhuseleko.
Impembelelo kwiZigulane nakwiMpilo yoLuntu
Le meko ibonakalisa imingcipheko ebalulekileyo kubantu abasebenzisa i-Ozempic okanye i-Wegovy. Ngaphandle kwengxelo yesiganeko esibi esifanelekileyo, iziphumo ebezingalindelekanga ezinokubakho zisenokungaqatshelwa. Oku kunokulibazisa uhlaziyo olubalulekileyo lokhuseleko kunye nezigqibo zonyango ezinefuthe.
Intembeko yoluntu kwiinkampani ezixuba amayeza nayo isesichengeni. Ulongamelo olusemthethweni luqinisekisa ukuba abavelisi bamachiza babeka phambili impilo-ntle yesigulana. Isenzo se-FDA sisebenza njengesikhumbuzo sokubaluleka kokuthotyelwa.
Kwezinye iindaba zempilo nokhuseleko, PEGI's new age ratings ziyakukhawulela iFC 27 kubantwana abangaphezulu kweminyaka eyi-16, ebonisa ukuba amanyathelo olawulo avela njani kubathengi bonke.
Amanyathelo Alandelayo eNovo Nordisk
I-Novo Nordisk kufuneka iphendule kwisilumkiso se-FDA ngesicwangciso sesenzo sokulungisa. Inkampani kufuneka ijongane nalo lonke ulwaphulo-mthetho oluphawulweyo ngokukhawuleza. Oku kunokuquka ukulungisa iinkqubo zabo zokunika ingxelo ngesiganeko esibi.
Ukungaphumeleli ukuthobela kungabangela ezinye izenzo zolawulo. Oku kunokubandakanya izohlwayo, izithintelo, okanye ukukhunjuzwa kwemveliso. Isigebenga soxubo-mayeza kunye nokuma kwemarike kusemngciphekweni.
Iimpembelelo eziBanzi kuShishino lwe-Pharma
Imiqondiso yendlela engqongqo ye-FDA yonyusa uphononongo ekujongweni kukhuseleko lwamachiza. Ezinye iinkampani ezixuba amayeza kufuneka zithathele ingqalelo kwaye zivavanye iindlela zazo. Ukuthobela ngokuthe ngqo kunokuthintela imiba efanayo.
Utshintsho kubuchwephesha, obufana nobo bubonwa umenzi we-humanoid robotics NgeCawa ufikelela kuqikelelo lwe-$1.15B ukwakha iirobhothi zasekhaya, zinokudlala indima yokuphuhlisa ikhemesti kunye nokuphucula idatha kwixa elizayo.
Ukwenza izinto elubala kunye nokunika ingxelo ngexesha akuxoxiswana. Abalulekile ekugcineni ukuzithemba koluntu kunye nokuqinisekisa ukuba amayeza asindisa ubomi ahlala ekhuselekile kumntu wonke.
Isiphelo
Isilumkiso se-FDA esiya kwi-Novo Nordisk ngokusweleka okungaxelwanga kunye nolwaphulo-mthetho olumandla lugxininisa imfuneko ebalulekileyo yokhuseleko olungqongqo kumayeza. Ukuhlala unolwazi malunga nophuhliso olunjalo kunceda wonke umntu enze izigqibo ezingcono zempilo. Ukufumana ulwazi oluninzi ngempilo, ubuchwepheshe, kunye nohlaziyo lolawulo, jonga umxholo ohambelanayo kwiSeemless.
